GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review

GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH56947FSA
  • |
  • Pages: 50
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

GW Pharmaceuticals Plc (GWP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company's commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing products for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy syndrome, glioma, schizophrenia, autism among others. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc Key Recent Developments

May 08,2018: GW Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results

Feb 05,2018: GW Pharmaceuticals Reports Q1 Fiscal 2018 Financial Results

Dec 21,2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors

Dec 04,2017: GW Pharmaceuticals Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress

Aug 07,2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

GW Pharmaceuticals Plc-Key Facts 6

GW Pharmaceuticals Plc-Key Employees 7

GW Pharmaceuticals Plc-Key Employee Biographies 8

GW Pharmaceuticals Plc-Major Products and Services 9

GW Pharmaceuticals Plc-History 10

GW Pharmaceuticals Plc-Company Statement 13

GW Pharmaceuticals Plc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

GW Pharmaceuticals Plc-Business Description 16

Business Segment: Commercial 16

Overview 16

Performance 16

Business Segment: Pipeline R&D 16

Overview 16

Performance 16

Business Segment: Sativex R&D 16

Overview 16

Performance 17

Geographical Segment: Asia/Other 17

Performance 17

Geographical Segment: Canada 17

Performance 17

Geographical Segment: Europe (Excluding the UK) 17

Performance 17

Geographical Segment: The UK 17

Performance 17

Geographical Segment: The US 17

Performance 17

R&D Overview 18

GW Pharmaceuticals Plc-Corporate Strategy 19

GW Pharmaceuticals Plc-SWOT Analysis 20

SWOT Analysis-Overview 20

GW Pharmaceuticals Plc-Strengths 20

GW Pharmaceuticals Plc-Weaknesses 21

GW Pharmaceuticals Plc-Opportunities 22

GW Pharmaceuticals Plc-Threats 23

GW Pharmaceuticals Plc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

GW Pharmaceuticals Plc, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Dec 21, 2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors 35

Dec 04, 2017: GW Pharmaceuticals Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress 36

Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 38

May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 40

May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 41

Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director-UK 43

Feb 23, 2017: First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals 44

Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 45

Section 6-Appendix 46

Methodology 46

Ratio Definitions 46

About GlobalData 50

Contact Us 50

Disclaimer 50

List of Figures

GW Pharmaceuticals Plc, Performance Chart (2013-2017) 29

GW Pharmaceuticals Plc, Ratio Charts 31

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

List of Tables

GW Pharmaceuticals Plc, Key Facts 6

GW Pharmaceuticals Plc, Key Employees 7

GW Pharmaceuticals Plc, Key Employee Biographies 8

GW Pharmaceuticals Plc, Major Products and Services 9

GW Pharmaceuticals Plc, History 10

GW Pharmaceuticals Plc, Other Locations 14

GW Pharmaceuticals Plc, Subsidiaries 14

GW Pharmaceuticals Plc, Key Competitors 24

GW Pharmaceuticals Plc, Ratios based on current share price 25

GW Pharmaceuticals Plc, Annual Ratios 26

GW Pharmaceuticals Plc, Annual Ratios (Cont...1) 27

GW Pharmaceuticals Plc, Annual Ratios (Cont...2) 28

GW Pharmaceuticals Plc, Interim Ratios 30

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

GW Pharmaceuticals Plc, Recent Deals Summary 34

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Zynerba Pharmaceuticals Inc

Zogenix Inc

Sinclair Pharma Plc

Oxford BioMedica Plc

Napp Pharmaceuticals Ltd

Insys Therapeutics Inc

Immupharma Plc

Evotec AG

Echo Pharmaceuticals BV

Contango Asset Management Ltd

Biogen Inc

AstraZeneca Plc

GW Pharmaceuticals Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8905
Site License
USD 250 INR 17810
Corporate User License
USD 375 INR 26715

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com